CN102946855B - 含有妥布霉素和地塞米松的局部用眼科混悬剂 - Google Patents

含有妥布霉素和地塞米松的局部用眼科混悬剂 Download PDF

Info

Publication number
CN102946855B
CN102946855B CN201080067666.9A CN201080067666A CN102946855B CN 102946855 B CN102946855 B CN 102946855B CN 201080067666 A CN201080067666 A CN 201080067666A CN 102946855 B CN102946855 B CN 102946855B
Authority
CN
China
Prior art keywords
composition
xanthan gum
tobramycin
viscosity
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080067666.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN102946855A (zh
Inventor
B·P·卡巴拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Research LLC
Original Assignee
Alcon Research LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Research LLC filed Critical Alcon Research LLC
Publication of CN102946855A publication Critical patent/CN102946855A/zh
Application granted granted Critical
Publication of CN102946855B publication Critical patent/CN102946855B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201080067666.9A 2010-06-23 2010-06-23 含有妥布霉素和地塞米松的局部用眼科混悬剂 Expired - Fee Related CN102946855B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/039618 WO2011162752A1 (en) 2010-06-23 2010-06-23 Topical ophthalmic suspensions containing tobramycin and dexamethasone

Publications (2)

Publication Number Publication Date
CN102946855A CN102946855A (zh) 2013-02-27
CN102946855B true CN102946855B (zh) 2016-01-06

Family

ID=44080140

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080067666.9A Expired - Fee Related CN102946855B (zh) 2010-06-23 2010-06-23 含有妥布霉素和地塞米松的局部用眼科混悬剂

Country Status (10)

Country Link
EP (1) EP2585037A1 (enExample)
JP (1) JP5728082B2 (enExample)
KR (1) KR20130094280A (enExample)
CN (1) CN102946855B (enExample)
AU (1) AU2010356098B2 (enExample)
BR (1) BR112012033052A2 (enExample)
CA (1) CA2801731A1 (enExample)
MX (1) MX2012015051A (enExample)
WO (1) WO2011162752A1 (enExample)
ZA (1) ZA201209240B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201208080D0 (en) * 2012-05-09 2012-06-20 Norton Healthcare Ltd Tobramycin formulation
JP6527315B2 (ja) * 2014-08-08 2019-06-05 Ｄｓｐ五協フード＆ケミカル株式会社 速溶性増粘剤、咀嚼・嚥下困難者用増粘剤及び咀嚼・嚥下困難者用飲食品
CN109260219B (zh) 2018-11-30 2021-03-09 山东省药学科学院 一种关节腔注射制剂及其应用
IT202000002296A1 (it) * 2020-02-06 2021-08-06 Sifi Spa Formulazioni topiche oftalmiche a base di xantano con ridotta posologia
ES2993434T3 (en) * 2020-05-12 2024-12-30 Probiotical Spa Compositions comprising bacterial strains and use thereof for use in the treatment of ocular diseases and lesions
IT202200000821A1 (it) * 2022-01-19 2023-07-19 Sifi Spa Formulazioni topiche oftalmiche a base di xantano con ridotta posologia
CN115006412B (zh) * 2022-05-20 2023-11-10 北京诺康达医药科技股份有限公司 一种复方妥布霉素滴眼液及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006023A1 (en) * 1997-07-29 1999-02-11 Alcon Laboratories, Inc. Ophthalmic compositions containing galactomannan polymers and borate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US5149694A (en) 1988-03-09 1992-09-22 Alcon Laboratories, Inc. Combination of tobramycin and dexamethasone for topical ophthalmic use
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
JP4545927B2 (ja) * 1998-04-07 2010-09-15 アルコン ラボラトリーズ， インコーポレイテッド キサンタンガムを含有するゲル化眼科用組成物
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
EP1305033B1 (en) 2000-07-28 2004-10-20 Alcon, Inc Pharmaceutical compositions containing tobramycin and xanthan gum

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006023A1 (en) * 1997-07-29 1999-02-11 Alcon Laboratories, Inc. Ophthalmic compositions containing galactomannan polymers and borate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis;MCCORMICK C ET AL;《CURRENT MEDICAL RESEARCH AND OPINION》;20080601;第24卷(第6期);第1569-1575页 *

Also Published As

Publication number Publication date
EP2585037A1 (en) 2013-05-01
MX2012015051A (es) 2013-02-15
AU2010356098B2 (en) 2014-08-14
JP5728082B2 (ja) 2015-06-03
AU2010356098A1 (en) 2013-01-10
KR20130094280A (ko) 2013-08-23
WO2011162752A1 (en) 2011-12-29
JP2013529632A (ja) 2013-07-22
CN102946855A (zh) 2013-02-27
BR112012033052A2 (pt) 2019-09-24
ZA201209240B (en) 2014-02-26
CA2801731A1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
US8450287B2 (en) Topical ophthalmic compositions containing tobramycin and dexamethasone
CN102946855B (zh) 含有妥布霉素和地塞米松的局部用眼科混悬剂
US11918573B2 (en) Ophthalmic formulations of cetirizine and methods of use
US20110105450A1 (en) Ophthalmic formulations of fluticasone and methods of use
AU2009345790B2 (en) Topical solution formulations containing a corticosteroid and a cyclodextrin
US20070110812A1 (en) Ophthalmic composition for dry eye therapy
TW202342108A (zh) 多劑量眼用組成物
US20080306039A1 (en) Loteprednol Etabonate Aqueous Suspension
CN116847826A (zh) 包含左氧氟沙星和酮咯酸的眼用组合物、其制备方法和用途
WO2022238251A2 (en) Ophthalmic pharmaceutical composition comprising atropine
WO2025192685A1 (ja) デキサメタゾンを含む医薬組成物
MXJL05000034A (es) Una formulacion oftalmica topica y su uso.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160106

Termination date: 20170623